Home › NDC Lookup › RxCUI directory › RxCUI 199148

Lamivudine 10 MG/ML Oral Solution — RxCUI 199148

RxNorm drug concept · Semantic clinical drug
RxCUI 199148 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199148
Official nameLamivudine 10 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as3TC 10 MG/ML Oral Solution; lamiVUDine 10 MG in 1 mL Oral Solution; lamivudine 10 MG per 1 ML Oral Solution
FDA products mapped7
Package NDCs mapped8
Reported Medicaid activity (SDUD)1,055 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lamivudine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It can be used for both, but here's the important thing: there are two different products, and they are not the same. The higher-dose tablets and oral solution (like Epivir) are us...
  • What exactly is lamivudine used for — is it for HIV or hepatitis B?
  • Please don't stop without talking to your doctor first. If you have HIV-1, stopping can allow the virus to rebound. If you're also infected with hepatitis B, stopping lamivudine ca...
  • Can I stop taking lamivudine if I feel fine?
📖 Read our full Lamivudine guide →

🕸️ Concept Web — How Lamivudine 10 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lamivudine 10 MG/ML Oral Solution RxCUI 199148

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lamivudine 68244
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Epivir 196478
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lamivudine Oral Solution 372562
    • Lamivudine Oral Liquid Product 1162818
    • Lamivudine Oral Product 1162819
    • Lamivudine Oral Solution [Epivir] 364697
    • Epivir Oral Liquid Product 1167629
    • Epivir Oral Product 1167630
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lamivudine 10 MG/ML SCDC · 316126
  • Lamivudine Oral Solution SCDF · 372562
  • Lamivudine Oral Liquid Product SCDG · 1162818
  • Lamivudine Oral Product SCDG · 1162819

Brand-Name Concepts

  • Lamivudine 10 MG/ML Oral Solution [Epivir] SBD · 152932
  • Lamivudine 10 MG/ML [Epivir] SBDC · 565112
  • Lamivudine Oral Solution [Epivir] SBDF · 364697
  • Epivir Oral Liquid Product SBDG · 1167629
  • Epivir Oral Product SBDG · 1167630
  • Epivir BN · 196478

📦 FDA Products & Package NDCs

7 products · 8 package NDCs
8 package NDCs map to RxCUI 199148 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49702-0203-18 60 TABLET, FILM COATED in 1 BOTTLE (49702-203-18) EPIVIR ViiV Healthcare Company 2010-10-04
49702-0204-13 30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13) EPIVIR ViiV Healthcare Company 2010-10-04
49702-0205-48 240 mL in 1 BOTTLE (49702-205-48) EPIVIR ViiV Healthcare Company 2010-10-04
57237-0274-24 240 mL in 1 BOTTLE (57237-274-24) Lamivudine Rising Pharma Holdings, Inc. 2016-11-21
62135-0706-24 2 TRAY in 1 BOX (62135-706-24) / 10 CUP in 1 TRAY / 30 mL i... lamivudine Chartwell RX, LLC 2025-03-06
62135-0706-37 240 mL in 1 BOTTLE, PLASTIC (62135-706-37) lamivudine Chartwell RX, LLC 2023-07-20
65862-0055-24 240 mL in 1 BOTTLE (65862-055-24) Lamivudine Aurobindo Pharma Limited 2016-11-21
68999-0706-24 2 TRAY in 1 BOX (68999-706-24) / 10 CUP in 1 TRAY / 30 mL i... lamivudine Chartwell Govermental & Specialty RX, LLC. 2025-12-24
Observed labelers: ViiV Healthcare Company (3) · Chartwell RX, LLC (2) · Aurobindo Pharma Limited (1) · Chartwell Govermental & Specialty RX, LLC. (1) · Rising Pharma Holdings, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.